These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 25117499)
1. Advantages of crystallographic fragment screening: functional and mechanistic insights from a powerful platform for efficient drug discovery. Patel D; Bauman JD; Arnold E Prog Biophys Mol Biol; 2014; 116(2-3):92-100. PubMed ID: 25117499 [TBL] [Abstract][Full Text] [Related]
2. Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin. Wollenhaupt J; Barthel T; Lima GMA; Metz A; Wallacher D; Jagudin E; Huschmann FU; Hauß T; Feiler CG; Gerlach M; Hellmig M; Förster R; Steffien M; Heine A; Klebe G; Mueller U; Weiss MS J Vis Exp; 2021 Mar; (169):. PubMed ID: 33749678 [TBL] [Abstract][Full Text] [Related]
3. Fast fragment and compound screening pipeline at the Swiss Light Source. Stegmann DP; Steuber J; Fritz G; Wojdyla JA; Sharpe ME Methods Enzymol; 2023; 690():235-284. PubMed ID: 37858531 [TBL] [Abstract][Full Text] [Related]
4. Crystallographic fragment screening in academic cancer drug discovery. Martin MP; Endicott JA; Noble MEM; Tatum NJ Methods Enzymol; 2023; 690():211-234. PubMed ID: 37858530 [TBL] [Abstract][Full Text] [Related]
6. Fast fragment- and compound-screening pipeline at the Swiss Light Source. Kaminski JW; Vera L; Stegmann DP; Vering J; Eris D; Smith KML; Huang CY; Meier N; Steuber J; Wang M; Fritz G; Wojdyla JA; Sharpe ME Acta Crystallogr D Struct Biol; 2022 Mar; 78(Pt 3):328-336. PubMed ID: 35234147 [TBL] [Abstract][Full Text] [Related]
7. Predicting the success of fragment screening by X-ray crystallography. Davies DR; Begley DW; Hartley RC; Staker BL; Stewart LJ Methods Enzymol; 2011; 493():91-114. PubMed ID: 21371588 [TBL] [Abstract][Full Text] [Related]
8. The genesis of high-throughput structure-based drug discovery using protein crystallography. Kuhn P; Wilson K; Patch MG; Stevens RC Curr Opin Chem Biol; 2002 Oct; 6(5):704-10. PubMed ID: 12413557 [TBL] [Abstract][Full Text] [Related]
9. Achieving a Good Crystal System for Crystallographic X-Ray Fragment Screening. Collins PM; Douangamath A; Talon R; Dias A; Brandao-Neto J; Krojer T; von Delft F Methods Enzymol; 2018; 610():251-264. PubMed ID: 30390801 [TBL] [Abstract][Full Text] [Related]
10. In-plate protein crystallization, in situ ligand soaking and X-ray diffraction. le Maire A; Gelin M; Pochet S; Hoh F; Pirocchi M; Guichou JF; Ferrer JL; Labesse G Acta Crystallogr D Biol Crystallogr; 2011 Sep; 67(Pt 9):747-55. PubMed ID: 21904027 [TBL] [Abstract][Full Text] [Related]
11. Screening Ligands by X-ray crystallography. Davies DR Methods Mol Biol; 2014; 1140():315-23. PubMed ID: 24590727 [TBL] [Abstract][Full Text] [Related]